Clinical trial Recruiting at 1 site Observational Ages 18 to 90

Understanding muscle loss in heart failure patients

Official title: Socioeconomic Factors and Mechanisms of Sarcopenia and Muscle Strength in Chronic Heart Failure Patients

Run by Aarhus University Hospital · NCT05063955 · Data updated 2026-11-12

This study looks at how factors like lifestyle and nutrition affect muscle loss in people with heart failure compared to healthy individuals.

Quick facts

Study typeObservational
Ages18 Years to 90 Years
SexAll
Enrollment250 (estimated)
SponsorAarhus University Hospital
Academic / other
Locations1 site (Aarhus N)
StatusRecruiting
StartedDecember 2, 2020
Main results expectedDecember 31, 2026
Study endsDecember 31, 2033
Registry record updatedDecember 26, 2023
Trial IDNCT05063955 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals with heart failure of any ejection fraction (NYHA I-IV) who can provide informed consent.

Probably not a fit

Patients with severe musculoskeletal or neurological disabilities, severe lung disease, or those on anticoagulant treatment may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to explore how socioeconomic factors, daily physical activity, nutrition, and lifestyle contribute to muscle mass and function loss in patients with heart failure. It will involve 200 heart failure patients and 50 healthy controls matched by age and sex. Researchers will collect baseline data on body composition, physical capacity, nutritional status, and quality of life, along with skeletal muscle biopsies and blood samples for analysis. Follow-up visits will occur at 12 and 36 months to assess changes over time.

Why it matters

Potential benefit: If successful, this study could lead to improved understanding and management of muscle loss in heart failure patients, potentially enhancing their quality of life.

How similar studies have gone: While the specific interactions being studied may be novel, similar studies have shown that understanding the relationship between muscle loss and heart failure can lead to better patient outcomes.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Ability to provide valid informed consent.
2. Heart failure with preserved, mid-range or reduced ejection fraction (NYHA I-IV) according to European Society of Cardiology guidelines.

Exclusion Criteria:

1. Cancer requiring treatment (e.g. prostate cancer on watchful waiting does not exclude patients).
2. Severe musculoskeletal or neurological disability.
3. Severe lung disease with a forced expiratory volume 1 \< 40% of predicted. Treatment with anticoagulants (warfarin, apixaban, edoxaban, dabigatran and rivaroxaban) is an exclusion criterion for muscle biopsy. Patients with anticoagulant treatment will be invited to participate in the study without muscle biopsy.
4. Other comorbidities that prevent the patient from participating in the study examinations as judged by the investigator.

Where it's running

  • Aarhus University Hospital
    Aarhus N, Denmark
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.